Suicide

Expert Q&A

Communicating With Patients About Gender

Topics: Depression | Diversity | Gender | Gender Diverse | Gender Identity | LGBT | LGBTQ+ | Minority | Pronouns | Stigma | Suicide | TGD | Transgender

CCPR: Welcome, Dr. Keuroghlian. Please tell us what you do. Dr. Keuroghlian: At The Fenway Institute, I see transgender and gender-diverse (TGD)* patients in the behavioral health department. We also conduct education, training, technical assistance, and implementation with health systems and programs nationwide. I also direct the Gender Identity Progr

Read More
Research Update

Update: Is Watching 13 Reasons Why Bad for Teens?

Topics: 13 Reasons Why | Contagion | Media | Netflix | Suicide | teens

Review of: Bridge JA et al, J Am Acad Child Adolesc Psychiatry 2020;59(2):236–243 Netflix’s 13 Reasons Why (13RW) continues to generate controversy that it may do more harm than good amid the backdrop of an already increasing teen suicide rate, and CCPR has been watching the unfolding research (see Mar/Apr 2019 and Sept/Oct 2019 issues). Last tim

Read More
Research Update

Update: Is Watching 13 Reasons Why Bad for Teens?

Topics: Bullying | Contagion | Media | Prevention | Research Update | Risk | Suicidality | Suicide | teens

Review of: Niederkrotenthaler T et al, JAMA Psychiatry 2019. doi: 10.1001/jamapsychiatry.2019.0922 Several studies have examined whether Netflix’s 13 Reasons Why is good or bad for teens. Results have been mixed. In the CCPR March/April 2019 issue, we reported a study finding that most suicidal ideation decreased after watching the first season of

Read More
Research Update

Varenicline and Bupropion: Soaring Again With EAGLES?

Topics: Addiction | Addiction Treatment | Bupropion | Chantix | Co-occurring disorders | Dual diagnosis | FDA Warnings | Medication | Pharmacology | Research | Research Update | Side Effects | Smoking Cessation | Smoking Cessation Agents | Substance Use | Substance use disorders | Suicidality | Suicide | Tobacco | Varenicline | Wellbutrin

Review of: Anthenelli RM et al, Lancet 2016;387(10037):2507–2520 Varenicline (Chantix) and bupropion (Zyban and others) are effective treatments for tobacco use disorder, but their use (and sales) took a big hit in 2009 when the FDA slapped both with black box warnings linking them to psychiatric complications, including suicidal ideation. Although

Read More
Research Update

Locked-In Syndrome and Quality of Life

Topics: Physician assisted suicide | Suicide

Review of: Kuzma-Kozakiewicz M et al, Neurology 2019;93(10):e938–e945 Study Type: Observational cross-sectional Imagine being completely alert and aware but unable to move or speak. Patients with locked-in syndrome, a catastrophic result of neurologic disorders such as stroke or amyotrophic lateral sclerosis (ALS), live this way for years. Better of

Read More